| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
172,904 |
155,671 |
$13.02M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
78,569 |
71,148 |
$5.41M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
53,328 |
48,072 |
$4.45M |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
100,018 |
88,209 |
$2.29M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
25,796 |
23,227 |
$1.85M |
| S9083 |
Global fee urgent care centers |
14,236 |
12,422 |
$1.38M |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
31,524 |
25,486 |
$917K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
11,495 |
8,921 |
$824K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
101,487 |
45,758 |
$670K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
17,603 |
15,289 |
$477K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
44,681 |
39,780 |
$313K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
21,883 |
13,468 |
$73K |
| 99215 |
Prolong outpt/office vis |
872 |
789 |
$66K |
| 99205 |
Prolong outpt/office vis |
273 |
262 |
$26K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,129 |
918 |
$18K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
259 |
235 |
$16K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
224 |
183 |
$15K |
| 87807 |
|
2,034 |
1,637 |
$9K |
| 87430 |
|
953 |
658 |
$4K |
| 81003 |
|
5,115 |
4,103 |
$3K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
26 |
26 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
4,545 |
3,712 |
$2K |
| 0012A |
|
258 |
246 |
$1K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,915 |
1,319 |
$775.18 |
| 0011A |
|
254 |
230 |
$453.74 |
| 81025 |
|
677 |
488 |
$357.23 |
| 71046 |
Radiologic examination, chest; 2 views |
116 |
93 |
$191.70 |
| 74019 |
|
13 |
12 |
$153.37 |
| 99051 |
|
421 |
268 |
$85.60 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
24 |
16 |
$75.76 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,271 |
924 |
$14.99 |
| 82962 |
|
19 |
16 |
$5.40 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
90 |
69 |
$0.00 |
| J7510 |
Prednisolone oral, per 5 mg |
17 |
14 |
$0.00 |
| 74018 |
|
15 |
13 |
$0.00 |
| 73130 |
|
15 |
13 |
$0.00 |
| S9088 |
Services provided in an urgent care center (list in addition to code for service) |
474 |
436 |
$0.00 |
| 91301 |
|
42 |
39 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
24 |
16 |
$0.00 |
| A9150 |
Non-prescription drugs |
46 |
40 |
$0.00 |